Sinaf S.A.

This profile gathers the share dealings of Sinaf S.A. in Regenerx Biopharmaceuticals Inc. In total, 5 filings cover trades dated from 5 January 2011 to 13 March 2018.

In open-market terms, that means 1 purchase worth €263k on one side and 1 sale worth €2.2M on the other. Netting one side against the other leaves €1.9M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2018: no purchases and 1 sale on the market.

The record was last updated on 14 March 2018 with an open-market sale (€2.2M) in Regenerx Biopharmaceuticals Inc. The clock since the last published purchase (7 January 2011) now reads 5,768 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.